Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

Reinier Smit, Rob J. van Marum*, Nathalie C. Péquériaux, Daan A. Hollander, Michiel W.P. Bleeker, Yasamin Latify, Walter A. Hermens, H. J. Derijks

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)139-140
Number of pages2
JournalEuropean Journal of Clinical Pharmacology
Issue number1
Publication statusPublished - 1 Jan 2018

Cite this